128 related articles for article (PubMed ID: 6258839)
1. Plasma renin activity and plasma concentrations of norepinephrine and cyclic nucleotides in heart failure after prazosin.
Ogasawara B; Ogawa K; Hayashi H; Sassa H
Clin Pharmacol Ther; 1981 Apr; 29(4):464-71. PubMed ID: 6258839
[TBL] [Abstract][Full Text] [Related]
2. Effects of nitroglycerin ointment on plasma norepinephrine and cyclic nucleotides in congestive heart failure.
Ogasawara B; Ogawa K; Sassa H
J Cardiovasc Pharmacol; 1981; 3(4):867-75. PubMed ID: 6167816
[TBL] [Abstract][Full Text] [Related]
3. The contributions of sympathetic tone and the renin-angiotensin system to severe chronic congestive heart failure: response to specific inhibitors (prazosin and captopril).
Kluger J; Cody RJ; Laragh JH
Am J Cardiol; 1982 May; 49(7):1667-74. PubMed ID: 7044087
[TBL] [Abstract][Full Text] [Related]
4. Increase in plasma norepinephrine during prazosin therapy for chronic congestive heart failure.
Stein L; Henry DP; Weinberger MH
Am J Med; 1981 Apr; 70(4):825-32. PubMed ID: 7011023
[TBL] [Abstract][Full Text] [Related]
5. Increased plasma cyclic nucleotide concentrations in congestive heart failure.
Ogawa K; Shiozu H; Mizuno K; Ban M; Ito T; Satake T
Br Heart J; 1984 Nov; 52(5):524-9. PubMed ID: 6093837
[TBL] [Abstract][Full Text] [Related]
6. Pathophysiologic and prognostic considerations in circulatory insufficiency in congestive heart failure: receptor function.
Ogawa K; Ito T
Jpn Circ J; 1989 Feb; 53(2):123-30. PubMed ID: 2541267
[TBL] [Abstract][Full Text] [Related]
7. Acute and chronic cardiocirculatory effects of oral prazosin in chronic refractory heart failure.
Hayashi H; Sassa H; Oba M; Fukaya T; Okubo M; Niwa T; Matsui E
Jpn Heart J; 1980 Nov; 21(6):827-36. PubMed ID: 7007686
[TBL] [Abstract][Full Text] [Related]
8. Prazosin and captopril in chronic heart failure: comparison of acute haemodynamic and hormonal effects.
Sharpe DN; Coxon R
Aust N Z J Med; 1982 Oct; 12(5):483-8. PubMed ID: 6758746
[TBL] [Abstract][Full Text] [Related]
9. Contribution of the renin-angiotensin-aldosterone system to development of tolerance and fluid retention in chronic congestive heart failure during prazosin treatment.
Riegger GA; Haeske W; Kraus C; Kromer EP; Kochsiek K
Am J Cardiol; 1987 Apr; 59(8):906-10. PubMed ID: 3548307
[TBL] [Abstract][Full Text] [Related]
10. Differential long-term intrarenal and neurohormonal effects of captopril and prazosin in patients with chronic congestive heart failure: importance of initial plasma renin activity.
Mettauer B; Rouleau JL; Bichet D; Kortas C; Manzini C; Tremblay G; Chatterjee K
Circulation; 1986 Mar; 73(3):492-502. PubMed ID: 3512121
[TBL] [Abstract][Full Text] [Related]
11. Role of the renin-angiotensin system in the development of hemodynamic and clinical tolerance to long-term prazosin therapy in patients with severe chronic heart failure.
Packer M; Medina N; Yushak M
J Am Coll Cardiol; 1986 Mar; 7(3):671-80. PubMed ID: 2869077
[TBL] [Abstract][Full Text] [Related]
12. Attenuation of prazosin effect on cardiac output in chronic heart failure.
Arnold SB; Williams RL; Ports TA; Baughman RA; Benet LZ; Parmley WW; Chatterjee K
Ann Intern Med; 1979 Sep; 91(3):345-9. PubMed ID: 475164
[TBL] [Abstract][Full Text] [Related]
13. Relationship between atrial natriuretic polypeptide and cyclic 3'5'-guanosine monophosphate in human plasma.
Fujio N; Ohashi M; Nawata H; Kato K; Ibayashi H; Matsuo H
J Lab Clin Med; 1987 Jun; 109(6):706-10. PubMed ID: 3035037
[TBL] [Abstract][Full Text] [Related]
14. Hemodynamic, renal, and hormonal effects of 8-Br-cyclic GMP in conscious dogs with and without congestive heart failure.
Elsner D; Kromer EP; Riegger GA
J Cardiovasc Pharmacol; 1989 Aug; 14(2):241-7. PubMed ID: 2476597
[TBL] [Abstract][Full Text] [Related]
15. Vasodilatation with captopril and prazosin in chronic heart failure: double blind study at rest and on exercise.
Bayliss J; Canepa-Anson R; Norell MS; Poole-Wilson P; Sutton G
Br Heart J; 1986 Mar; 55(3):265-73. PubMed ID: 3513808
[TBL] [Abstract][Full Text] [Related]
16. Haemodynamic effects of a single low dose of prazosin in patients with chronic congestive cardiac failure correlations with pharmacokinetics.
Horowitz JD; Dynon MK; Jarrott B; Brennan JB; Oliver LE; Goble AJ; Louis WJ
Clin Exp Pharmacol Physiol; 1984; 11(1):7-15. PubMed ID: 6713738
[TBL] [Abstract][Full Text] [Related]
17. Differences in hemodynamic effects of nitroprusside and prazosin in severe chronic congestive heart failure: evidence for a direct negative chronotropic effect of prazosin.
Packer M; Meller J; Gorlin R; Herman MV
Am J Cardiol; 1979 Aug; 44(2):310-7. PubMed ID: 463769
[TBL] [Abstract][Full Text] [Related]
18. Beneficial hemodynamic response to chronic prazosin therapy in congestive heart failure.
Feldman RC; Ball RM; Winchester MA; Jaillon P; Kates RE; Harrison DC
Am Heart J; 1981 May; 101(5):534-40. PubMed ID: 7223593
[TBL] [Abstract][Full Text] [Related]
19. Physiologic mechanisms opposing the hemodynamic effects of prazosin.
Izzo JL; Horwitz D; Keiser HR
Clin Pharmacol Ther; 1981 Jan; 29(1):7-11. PubMed ID: 7460477
[TBL] [Abstract][Full Text] [Related]
20. Plasma level of norepinephrine and cyclic nucleotides following acute myocardial infarction.
Kondo T; Ogawa K; Ban M; Ogasawara B; Watanabe E; Satake T
Jpn Heart J; 1981 Jul; 22(4):593-603. PubMed ID: 6271999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
